Recruiting Phase 4 NCT06007547

Prophylactic Minimally Invasive Surfactant Evaluation

Trial Parameters

Condition Respiratory Distress Syndrome, Newborn

Sponsor Endeavor Health

Study Type INTERVENTIONAL

Phase Phase 4

Enrollment 200

Sex ALL

Min Age N/A

Max Age 15 Minutes

Start Date 2024-01-01

Completion 2025-12-31

All Conditions

Respiratory Distress Syndrome, Newborn Premature Birth

Interventions

Poractant Alfa

Brief Summary

The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?

Eligibility Criteria

Inclusion Criteria: * Gestational age \<30 weeks * Antenatal consent from Parent Exclusion Criteria: * Congenital anomalies * Alternate cause of respiratory distress

Related Trials

NCT06007547

Prophylactic Minimally Invasive Surfactant Evaluation

View Trial →

NCT06880016

Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE RESPIRATORY DISTRESS SYNDROME, NEWBORN TRIALS